Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor.

Drouet C, Bouillet L, Csopaki F, Colomb MG.

FEBS Lett. 1999 Sep 24;458(3):415-8.

2.
3.

Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity.

Richer MJ, Juliano L, Hashimoto C, Jean F.

J Biol Chem. 2004 Mar 12;279(11):10222-7. Epub 2003 Dec 29.

4.

Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.

Thibeault D, Massariol MJ, Zhao S, Welchner E, Goudreau N, Gingras R, Llinàs-Brunet M, White PW.

Biochemistry. 2009 Feb 3;48(4):744-53. doi: 10.1021/bi801931e.

PMID:
19119853
5.

The regulation of human factor XIIa by plasma proteinase inhibitors.

Pixley RA, Schapira M, Colman RW.

J Biol Chem. 1985 Feb 10;260(3):1723-9.

6.

Expression of active human C1 inhibitor serpin domain in Escherichia coli.

Lamark T, Ingebrigtsen M, Bjørnstad C, Melkko T, Mollnes TE, Nielsen EW.

Protein Expr Purif. 2001 Jul;22(2):349-58.

PMID:
11437612
8.

Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.

Mawatari S, Uto H, Ido A, Nakashima K, Suzuki T, Kanmura S, Kumagai K, Oda K, Tabu K, Tamai T, Moriuchi A, Oketani M, Shimada Y, Sudoh M, Shoji I, Tsubouchi H.

PLoS One. 2013 Dec 12;8(12):e82094. doi: 10.1371/journal.pone.0082094. eCollection 2013.

9.

Autocatalytic cleavage within classical swine fever virus NS3 leads to a functional separation of protease and helicase.

Lamp B, Riedel C, Wentz E, Tortorici MA, Rümenapf T.

J Virol. 2013 Nov;87(21):11872-83. doi: 10.1128/JVI.00754-13. Epub 2013 Aug 28.

11.

Identification of HIV-1 protease cleavage site in human C1-inhibitor.

Gerencer M, Burek V.

Virus Res. 2004 Sep 15;105(1):97-100.

PMID:
15325085
12.

Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.

McGivern DR, Masaki T, Lovell W, Hamlett C, Saalau-Bethell S, Graham B.

J Virol. 2015 May;89(10):5362-70. doi: 10.1128/JVI.03188-14. Epub 2015 Mar 4.

13.

Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.

Johnson CL, Owen DM, Gale M Jr.

J Biol Chem. 2007 Apr 6;282(14):10792-803. Epub 2007 Feb 8.

14.

Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.

Patston PA, Gettins P, Beechem J, Schapira M.

Biochemistry. 1991 Sep 10;30(36):8876-82.

PMID:
1888745
15.

Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.

Urbani A, Biasiol G, Brunetti M, Volpari C, Di Marco S, Sollazzo M, Orrú S, Piaz FD, Casbarra A, Pucci P, Nardi C, Gallinari P, De Francesco R, Steinkühler C.

Biochemistry. 1999 Apr 20;38(16):5206-15.

PMID:
10213628
16.

Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.

Stief TW, Aab A, Heimburger N.

Thromb Res. 1988 Mar 15;49(6):581-9.

PMID:
2455361
17.
18.
19.

Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.

Shiryaev SA, Ratnikov BI, Chekanov AV, Sikora S, Rozanov DV, Godzik A, Wang J, Smith JW, Huang Z, Lindberg I, Samuel MA, Diamond MS, Strongin AY.

Biochem J. 2006 Jan 15;393(Pt 2):503-11.

20.

Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity.

Lei YF, Yin W, Yang J, Lv X, Wei SH, An QX, Hu XB, Xu ZK.

Acta Virol. 2008;52(3):133-41.

PMID:
18999887

Supplemental Content

Support Center